Concepedia

Publication | Open Access

Preparation of Immunotoxin Herceptin-Botulinum and Killing Effects on Two Breast Cancer Cell Lines

25

Citations

27

References

2015

Year

Abstract

Toxin-Herceptin bioconjugation can be a potential candidate with increased efficiency for treating breast cancer patients with over expression of the HER2 receptor.

References

YearCitations

Page 1